HPLC -reversed phase high pressure liquid chromatography; MALDI-ToF -matrix-assisted laser desorption/ionization time of flight; TAMRA -tetramethyl-6-carboxyrhodamine; TIS -triisopropyl silane; TFAtrifluoroacetic acid.
deg cm 2 dmol -1 ) by normalizing for the concentration of peptide bonds. Aqueous peptide solutions (300 μL volume; 4-10 μM in peptide) were prepared in filtered (0.22 μm) 10 mM phosphate buffer, pH 7.4. CD spectra recorded in the presence of synthetic membranes are for lipid/peptide molar ratio of 100:1 (up to 1 mM total lipid, 4-10 μM peptide).
Linear Dichroism. Solution-phase flow linear dichroism spectroscopy was performed on a Jasco-810 spectropolarimeter using a photo elastic modulator 1/2 wave plate. A micro-volume quartz Couette flow cell with ~0.25 mm annular gap and quartz capillaries were purchased from Kromatec Ltd, UK. Molecular alignment is achieved through the constant flow of the sample solution between two coaxial cylinders -a stationary quartz rod and a rotating cylindrical capillary. LD spectra were acquired with laminar flow obtained by maintaining the rotation speed at 3000 rpm and processed by subtracting non-rotating baseline spectra. LD spectra recorded in the presence of synthetic membranes, DLPC and DLPC:DLPG (3:1), were prepared at a lipid:peptide molar ratio of 100:1 (3 mM total lipid, 30 μM peptide).
Synthetic membranes. Dilaurylphosphatidylcholine (DLPC) and its mixtures with dilaurylphosphatidylglycerol (DLPG)
were used to prepare zwitterionic and anionic membranes respectively using published protocols. s1 Typically, unilamellar vesicles of DLPC and DLPC-DLPG (3:1 molar ratio) were prepared by dissolving dry lipids in chloroform/methanol (2:1 v/v) followed by evaporating the solvents and hydrating the residue to 10 mg/mL total lipid concentration in 10 mM MOPS, 10 mM NaCl, pH 7.4. The suspension was then extensively vortexed, sonicated (30°C), and extruded using a hand-held extruder (Avanti polar lipids) (twenty times, polycarbonate filter, 0.1 μm) to give a clear solution, and analyzed (100 nm) by photon correlation spectroscopy.
Photon Correlation Spectroscopy. Vesicles were re-suspended to final concentration of 1 mg/mL and were analysed on a Zetasizer Nano (ZEN3600), Malvern Instruments (Worcestershire, UK). DLS batch measurements were carried out in a low volume disposable cuvette at 25°C. Hydrodynamic radii were obtained through the fitting of autocorrelation data using the manufactures software, Dispersion Technology Software (DTS version 5.10).
Cell culture
Human dermal fibroblasts (ATCC number PCS-201-012,) were maintained in Medium 106 with low serum growth supplement (Gibco) and antibiotics (gentamicin and amphotericin B) in 25 cm 2 flasks. For growth the cells were incubated at 37°C, 5% CO 2 .
Pichia pastoris (X33) yeast cells (Invitrogen) were incubated overnight in Yeast Peptone Dextrose media at 37°C, 220 rpm (orbital 50 mm).
Minimum inhibitory concentrations (MIC) were determined by broth microdilution on Escherichia coli (K12) according to the
Clinical and Laboratory Standards Institute. s2 Typically, 90 μL of 0.5 -1 x 106 CFU per ml of each bacterium in Mueller
Hinton media (plus cations) broth (Oxoid) were incubated in 96 well micro-titre plates with serial two-fold dilutions of the peptides from 100 μM to 0.78 μM. Minimum inhibitory concentrations (MIC's) were defined as the lowest peptide concentration with no visible growth of bacteria from the MIC micro-titer plates after 24 hours at 37 °C.
Electronic
Transfection assays
Peptide transfection: Exponentially growing human fibroblasts were cultured in two-well chambers (Labtek) at a seeding density of 10 3 cells/cm 2 overnight at 37°C, 5% CO 2 . Following incubation the culture medium was aspirated, and the cells were twice washed with Medium 106, which was followed up by incubation with fluorescently labeled peptide at set concentrations (0.1-10 μM), first for 15 min in serum-reduced Opti-MEM and then after washing with Medium 106 for up to 24 hours. Control experiments performed using free dyes and free DNAs (TAMRA-ssDNA and pEGFP) gave no transfection.
Liopfectamine-mediated transfection:
Human dermal fibroblasts were cultured as above in two-well chambers (Labtek), and were then transfected with pEGFP (0.2 μg) using Lipofectamine Ltx (Invitrogen) at about 40-60% confluency as recommended by to the proprietary protocols. After 3 hours of incubation cells were twice washed with Medium 106. EGFP expression was monitored at different time points (from 3 hours to over a week) using confocal fluorescent microscopy.
Transfection of peptide/DNA complexes: Peptide/TAMRA-ssDNA and peptide/pEGFP complexes (P/N ratios 0.2-1, with pEGFP at 0.2 μg) were incubated with the same cell population as above for 30 min and 3 hours respectively in serumreduced Opti-MEM. Cells were then twice washed and incubated with Medium 106.
Peptide transfection into Pichia pastoris:
Following an overnight incubation at 37 °C, 220 rpm, P. pastoris cells were centrifuged, the pellet was re-suspended in PBS to obtain OD600nm = 0.5 AU. The cells were incubated with the fluorescently labeled peptide at 10 μM for 30 min, upon which cells were centrifuged and washed with PBS.
For all assays, 10-μL cell suspensions were mounted onto glass microscope slides and observed using confocal fluorescence microscopy.
Confocal fluorescence microscopy
Fluorescence was monitored using an Olympus IX81 confocal microscope at 488 nm using an x60 objective with appropriate filter. Life cell imaging was performed under controlled environmental conditions (37 °C, 5% CO2). Images (2D and 3D stacks) were processed using Imaris v5.1 and Image J software. Table and Figures   Table S1 . Peptide and DNA constructs used in the study . CD spectra for GeT at 60 μM (solid line and black discs) and 100 μM (dashed line and white discs) in phosphate buffer pH 7.4.
